Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS

FGEN Stock Annual Cash Flow. Download in Excel

FibroGen Inc logo

FibroGen Inc

Sector: Healthcare   

Industry: Biotechnology

0.40
 
USD
  
0.05
  
(13.09%)
Previous close: 0.3537  Open: 0.35  Bid: 0.4198  Ask: 0.43
52 week range    
0.18   
   2.93
Mkt Cap: 35 M  Avg Vol (90 Days): 1,142,037
Peers   
ILMN / 
A / 
HBIO / 
Last updated: Sunday 22nd December 2024

Stock Rankings

53
MarketXLS Rank
60
Value
61
Technical
39
Quality
How are these ranks calculated?
Search for a stock

Financials

FGEN Cash Flow

Annual
Invalid dateDec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22Dec-23
(Increase) Decrease in inventories-7 M-9 M-14 M-11 M-2 M
(Increase) Decrease in other current assets-420000.0-136000.0-2 M1 M
(Increase) Decrease in other current liabilities32 M19 M2 M-3 M-50 M45 M58 M-4 M-28 M
(Increase) Decrease in other working capital49 M-21 M-17 M-18 M-2 M
(Increase) Decrease in payables2 M-298000.0-714000.04 M-3 M18 M805000.06 M-16 M
(Increase) Decrease in receivables-2 M5 M2 M-55 M35 M-12 M25 M765000.03 M
Acquisitions-25 M-35 M
AssetImpairmentCharge1000000.0
CapitalExpenditureReported2 M1 M9 M8 M6 M4 M5 M4 M3 M
Cash at beginning of period165 M153 M174 M674 M89 M126 M678 M171 M156 M
Cash at end of period153 M174 M674 M89 M126 M678 M171 M156 M114 M
Cash flow-19 M7 M-67 M-76 M-79 M82 M-82 M-146 M-315 M
CashFlowFromContinuingInvestingActivities-6 M7 M70 M-522 M120 M452 M-427 M89 M154 M
ChangeInAccountPayable2 M-298000.0-714000.04 M-3 M18 M805000.06 M-16 M
ChangeInAccruedExpense-2 M3 M9 M6 M18 M31 M16 M91 M-50 M
ChangeInInterestPayable-2 M3 M9 M6 M
ChangeInPayablesAndAccruedExpense-156000.03 M8 M9 M15 M49 M17 M96 M-65 M
ChangeInPrepaidAssets978000.01 M-2 M-129000.0-129 M123 M-10 M5 M-28 M
ChangeInWorkingCapital30 M27 M8 M-48 M-86 M175 M59 M69 M-122 M
ChangesInAccountReceivables-2 M5 M2 M-55 M35 M-12 M25 M765000.03 M
Depreciation6 M6 M6 M7 M11 M12 M10 M10 M10 M
Depreciation unreconciled9 M9 M8 M7 M18 M22 M17 M12 M5 M
DepreciationAndAmortization9 M9 M8 M7 M18 M22 M15 M11 M10 M
Effect of exchange rate changes-38000.0-10000.051000.0-8000.0-5000.05 M3 M-5 M-3 M
FinancingCashFlow12 M7 M496 M14 M-4 M13 M-563000.047 M123 M
Free cash flow-21 M6 M-75 M-84 M-84 M78 M-87 M-150 M-318 M
GainLossOnInvestmentSecurities-203000.0-37000.0-143000.0-87000.0258000.05000.0271000.0
GainLossOnSaleOfPPE98000.03000.053000.0-42000.0933000.0233000.0-1000.04000.0
InterestPaidSupplementalData335000.0295000.0255000.0218000.0174000.0135000.094000.0104000.054000.0
Issuance of capital stock15 M10 M35 M30 M21 M38 M13 M4 M52 M
IssuanceOfCapitalStock15 M10 M35 M30 M21 M38 M13 M4 M52 M
IssuanceOfDebt-403000.0-403000.0-403000.0-360000.0-403000.0-403000.0-403000.0-403000.071 M
Net cash from financing activities12 M7 M496 M14 M-4 M13 M-563000.047 M123 M
Net cash from investing activities-6 M7 M70 M-522 M120 M452 M-427 M89 M154 M
Net cash from operating activities-19 M7 M-67 M-76 M-79 M82 M-82 M-146 M-315 M
Net change in cash & cash equivalents-12 M20 M500 M-584 M37 M552 M-510 M-10 M-39 M
Net income from continuing operations-86 M-62 M-121 M-86 M-77 M-189 M-290 M-294 M-284 M
NetBusinessPurchaseAndSale-25 M-35 M656000.0
NetCommonStockIssuance15 M10 M35 M30 M21 M38 M13 M4 M52 M
NetForeignCurrencyExchangeGainLoss-1 M
NetInvestmentPropertiesPurchaseAndSale-4 M8 M78 M-514 M126 M456 M-397 M128 M156 M
NetInvestmentPurchaseAndSale-4 M8 M78 M-514 M126 M456 M-397 M128 M156 M
NetIssuancePaymentsOfDebt-403000.0-403000.0-403000.0-360000.0-403000.0-403000.0-403000.0-403000.071 M
NetLongTermDebtIssuance-403000.0-403000.0-403000.0-360000.0-403000.0-403000.0-403000.0-403000.071 M
NetPPEPurchaseAndSale-2 M-1 M-8 M-8 M-6 M-4 M-5 M-4 M-3 M
Operating (gains) losses-105000.0-37000.0-140000.0-1 M-42000.01 M233000.04000.0275000.0
Other financing charges net-2 M-3 M462 M-16 M-25 M-24 M-13 M43 M-385000.0
Other investing changes net-169000.0-577 M-411 M8 M4 M7 M7 M
Other non-cash items28 M33 M39 M53 M66 M73 M131 M66 M86 M
Purchase of Float term investments-42 M-9 M-169000.0-8 M-484 M-164 M-252 M
Purchase of property plant & equipment-2 M-1 M-8 M-8 M-6 M-4 M-5 M-4 M-3 M
Purchase of short term investments49000.074 M
PurchaseOfInvestment-42 M-9 M-169000.0-8 M-484 M-164 M-252 M
PurchaseOfPPE-2 M-1 M-8 M-8 M-6 M-4 M-5 M-4 M-3 M
Repayment of debt-403000.0-403000.0-403000.0-409000.0-403000.0-403000.0-403000.0-403000.0-3 M
RepaymentOfDebt-403000.0-403000.0-403000.0-409000.0-403000.0-403000.0-403000.0-403000.0-3 M
Revenue per share3 M3 M2 M-42000.07 M10 M7 M2 M-5 M
Sale of short term investments38 M17 M79 M63 M537 M457 M83 M284 M401 M
SaleOfBusiness656000.0
SaleOfInvestment38 M17 M79 M63 M537 M457 M83 M284 M401 M
SaleOfPPE2000.05000.0184000.07000.06000.0
StockBasedCompensation28 M32 M38 M52 M66 M73 M71 M66 M51 M
UnrealizedGainLossOnInvestmentSecurities2000.0
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University